Carotid artery stent placement

JACC Cardiovasc Interv. 2010 May;3(5):467-74. doi: 10.1016/j.jcin.2010.04.002.

Abstract

In the past 3 years, there have been significant developments in the field of carotid revascularization, including: 1) the results of a large primary stroke prevention trial; 2) the emergence of novel platforms for emboli protection; 3) improved characterization of the high-risk carotid artery stent (CAS) patient; 4) completion of several very large post-market surveillance (PMS) trials of CAS in high-surgical-risk patients; and 5) the completion of 4 large randomized controlled trials comparing CAS with carotid endarterectomy in average-risk patients. The purpose of this review is to update the current status of revascularization therapies to reduce stroke in patients with extracranial carotid artery disease with a focus on the most recent developments regarding the role of CAS.

Publication types

  • Review

MeSH terms

  • Aged
  • Aged, 80 and over
  • Angioplasty / adverse effects
  • Angioplasty / instrumentation*
  • Angioplasty / mortality
  • Carotid Artery Diseases / mortality
  • Carotid Artery Diseases / surgery
  • Carotid Artery Diseases / therapy*
  • Endarterectomy, Carotid* / adverse effects
  • Endarterectomy, Carotid* / mortality
  • Evidence-Based Medicine
  • Humans
  • Odds Ratio
  • Patient Selection
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Risk Factors
  • Stents*
  • Stroke / etiology
  • Stroke / mortality
  • Stroke / prevention & control*
  • Time Factors
  • Treatment Outcome